The development of a rapid and simple method for the diagnostic testing of pathogenic bacteria in platelet products is proposed. The technical approach is based on a novel implementation of impedance sensing to monitor cellular growth with unprecedented sensitivity and stability. This enables results to be obtained directly from platelet samples within hours with a simple, inexpensive, and easy to use device ideally suited for mass production. The innovative method avoids the need for high cell densities, thus reducing the time from sample collection to detection of bacterial contamination from days to hours. Feasibility of the diagnostic tool will be demonstrated with several of the clinically significant bacterial strains which are often implicated in transfusion-related sepsis. ? ?

Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43FD001643-01A1
Application #
6879291
Study Section
Special Emphasis Panel (ZRG1-HEME-E (10))
Program Officer
Ganti, Usha
Project Start
2005-09-30
Project End
2006-08-28
Budget Start
2005-09-30
Budget End
2006-08-28
Support Year
1
Fiscal Year
2005
Total Cost
Indirect Cost
Name
Biosense Technologies, Inc.
Department
Type
DUNS #
122648533
City
Woburn
State
MA
Country
United States
Zip Code
01801